EMEA-003581-PIP01-24

EMEA-003525-PIP01-23

EMEA-003459-PIP01-23

Newsletters

PRIME: 5 years' experience

Human medicines European public assessment report (EPAR): Pavblu, aflibercept, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR): Phesgo, pertuzumab,trastuzumab, Date of authorisation: 21/12/2020, Revision: 6, Status: Authorised

Human medicines European public assessment report (EPAR): Januvia, sitagliptin, Date of authorisation: 20/03/2007, Revision: 34, Status: Authorised

Scientific advice and protocol assistance adopted during the CHMP meeting 19-22 May 2025

Q&A clinic on eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) service, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 18 September 2025, 14:00 (CEST) to 18 September 2025, 15:00 (CEST)